LISSONI, ANDREA ALBERTO

LISSONI, ANDREA ALBERTO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 116 (tempo di esecuzione: 0.03 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Fertility outcomes in stage I ovarian immature teratomas 01 - Articolo su rivista 2024 Marino G.De Ponti E.Testa F.Negri S.Seca M.Bombelli M.Santagati A.Bertoni M.Lissoni A. A.Landoni F.Fruscio R. +
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 01 - Articolo su rivista 2024 Marino, GiuseppeGrassi, TommasoDe Ponti, ElenaNegri, SerenaTesta, FilippoGiuliani, DanielaDell'Oro, CristinaFumagalli, DilettaDonatiello, GianlucaBesana, GiuliaMarchetta, LilianaLissoni, Andrea AlbertoLandoni, FabioFruscio, Robert +
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 01 - Articolo su rivista 2024 Bianchi T.Grassi T.Testa F.Corti J.Pecis Cavagna G.Bombelli M.Lissoni A. A.Trezzi G.De Ponti E.Fruscio R.Landoni F. +
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 01 - Articolo su rivista 2023 Cordani N.Bianchi T.Cortinovis D. L.Cazzaniga M. E.Lissoni A. A.Landoni F. +
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 01 - Articolo su rivista 2023 Colombo, NicolettaLandoni, FabioLissoni, Andrea +
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 01 - Articolo su rivista 2022 Adorni M.Lissoni A. A.Negri S.Grassi T.Buda A.Landoni F. +
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer 01 - Articolo su rivista 2022 Colombo N.Lissoni A. A. +
Response to chemotherapy and Clinical Outcome of Patients with recurrent epithelial ovarian cancer after PARP inhibitor maintenance treatment: a Multicenter retrospective italina Study 01 - Articolo su rivista 2022 Fabio LandoniAndrea Alberto Lissoni +
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 01 - Articolo su rivista 2021 Colombo, NicolettaLissoni, Andrea Alberto +
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 01 - Articolo su rivista 2021 LISSONI A. A.FERRARI D.DI MEO M. L.LANDONI F. +
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 01 - Articolo su rivista 2021 Ceppi L.Grassi T.Buda A.Lissoni A. A.Adorni M.Colombo N.Bonazzi C.Landoni F.Fruscio R. +
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 01 - Articolo su rivista 2021 Conconi D.Redaelli S.Lissoni A. A.Cilibrasi C.Sala E.Paderno M.Landoni F.Lavitrano M.Roversi G.Bentivegna A. +
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial 01 - Articolo su rivista 2021 Lissoni, Andrea A +
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 01 - Articolo su rivista 2021 Colombo N.Lissoni A. A. +
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 01 - Articolo su rivista 2020 Lissoni, Andrea AlbertoAdorni, MarcoLandoni, Fabio +
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 01 - Articolo su rivista 2020 Lissoni A. A. +
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial 01 - Articolo su rivista 2019 Lissoni A. +
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 01 - Articolo su rivista 2019 Giuliani, DLissoni, ALandoni, F +
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer 01 - Articolo su rivista 2019 Colombo, NicolettaLissoni, Andrea A +
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 01 - Articolo su rivista 2019 DELLE MARCHETTE, MARTINACeppi, LorenzoAndreano, AnitaBuda, AlessandroGRASSI, TOMMASOGiuliani, DanielaSina, FedericaLamanna, MariaBianchi, TommasoLissoni, Andrea AlbertoLandoni, FabioValsecchi, Maria GraziaFruscio, Robert +